- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Michael Kolodziej Discusses Taking on 2-Sided Risk in OCM After PP4 Results
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., discusses the move to 2-sided risk in the Oncology Care Model (OCM).
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., discusses the move to 2-sided risk in the Oncology Care Model (OCM).
Transcript
We're at a transformative time now with the OCM, with performance period 4 results out now with some practices having to either take on 2-sided risk or leave the model. What's the mindset of these practices right now?
You’d have to ask them. So, in general, I think physicians are risk averse. I think it’s pretty clear, and this is based on what [Center for Medicare and Medicaid Innovation] has told us, that a quarter of the practices aren’t close. Those guys are just going to quit. I think for the 35% or so of practices that are on the cusp, the question becomes if you do the math: I get the [Monthly Enhanced Oncology Services], I get the 5% bonus because of the advanced [alternative payment model], how far away am I and how can I manage that risk? And at least the scuttlebutt is that a lot of practices are engaging insurers to protect them from catastrophic loss.
So, they’re buying insurance against a bad outcome, which is not a bad idea because of the fact that we don’t know what therapies are going to come out in the next 5 years. We don’t know what the case mix is likely going to be in the next 5 years, and those are variables we cannot control. So even if you’ve done splendidly until this point, there’s still going to be risk going forward.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
